Literature DB >> 24001294

Acute and long-term effects of cannabis use: a review.

Laurent Karila, Perrine Roux, Benjamin Rolland, Amine Benyamina, Michel Reynaud, Henri-Jean Aubin, Christophe Lançon1.   

Abstract

Cannabis remains the most commonly used and trafficked illicit drug in the world. Its use is largely concentrated among young people (15- to 34-year-olds). There is a variety of cannabis use patterns, ranging from experimental use to dependent use. Men are more likely than women to report both early initiation and frequent use of cannabis. Due to the high prevalence of cannabis use, the impact of cannabis on public health may be significant. A range of acute and chronic health problems associated with cannabis use has been identified. Cannabis can frequently have negative effects in its users, which may be amplified by certain demographic and/or psychosocial factors. Acute adverse effects include hyperemesis syndrome, impaired coordination and performance, anxiety, suicidal ideations/tendencies, and psychotic symptoms. Acute cannabis consumption is also associated with an increased risk of motor vehicle crashes, especially fatal collisions. Evidence indicates that frequent and prolonged use of cannabis can be detrimental to both mental and physical health. Chronic effects of cannabis use include mood disorders, exacerbation of psychotic disorders in vulnerable people, cannabis use disorders, withdrawal syndrome, neurocognitive impairments, cardiovascular and respiratory and other diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24001294     DOI: 10.2174/13816128113199990620

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  61 in total

1.  The association between alcohol use trajectories from adolescence to adulthood and cannabis use disorder in adulthood: a 22-year longitudinal study.

Authors:  Jung Yeon Lee; Judith S Brook; Mario De La Rosa; Youngjin Kim; David W Brook
Journal:  Am J Drug Alcohol Abuse       Date:  2017-03-01       Impact factor: 3.829

Review 2.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

Review 3.  Cannabis effects on brain structure, function, and cognition: considerations for medical uses of cannabis and its derivatives.

Authors:  Alison C Burggren; Anaheed Shirazi; Nathaniel Ginder; Edythe D London
Journal:  Am J Drug Alcohol Abuse       Date:  2019-07-31       Impact factor: 3.829

4.  Does Marijuana Contribute to Intimate Partner Aggression? Temporal Effects in a Community Sample of Marijuana-Using Couples.

Authors:  Maria Testa; Jaye L Derrick; Weijun Wang; Kenneth E Leonard; Audrey Kubiak; Whitney C Brown; R Lorraine Collins
Journal:  J Stud Alcohol Drugs       Date:  2018-05       Impact factor: 2.582

Review 5.  Screening Medications for the Treatment of Cannabis Use Disorder.

Authors:  L V Panlilio; Z Justinova; J M Trigo; B Le Foll
Journal:  Int Rev Neurobiol       Date:  2016-03-10       Impact factor: 3.230

Review 6.  Pharmacology and adverse effects of new psychoactive substances: synthetic cannabinoid receptor agonists.

Authors:  Eun Yong Chung; Hye Jin Cha; Hyun Kyu Min; Jaesuk Yun
Journal:  Arch Pharm Res       Date:  2021-04-02       Impact factor: 4.946

7.  Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting.

Authors:  Mary Barna Bridgeman; Daniel T Abazia
Journal:  P T       Date:  2017-03

Review 8.  To flourish or perish: evolutionary TRiPs into the sensory biology of plant-herbivore interactions.

Authors:  Justyna B Startek; Thomas Voets; Karel Talavera
Journal:  Pflugers Arch       Date:  2018-09-18       Impact factor: 3.657

9.  Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.

Authors:  David S Jacobs; Stephen J Kohut; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

10.  Acute Toxicity Associated with Use of 5F-Derivations of Synthetic Cannabinoid Receptor Agonists with Analytical Confirmation.

Authors:  Rachelle Abouchedid; James H Ho; Simon Hudson; Alison Dines; John R H Archer; David M Wood; Paul I Dargan
Journal:  J Med Toxicol       Date:  2016-07-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.